Robert E. Landry - 27 Mar 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Mar 2023, 16:07:07 UTC
Prior SEC filing
07 Feb 2023
Next SEC filing
25 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/**Robert E. Landry

Key filing fact

Robert E. Landry filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 29 Mar 2023.

Key facts

  • This page summarizes Robert E. Landry's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
  • 22 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 29 Mar 2023, 16:07.

Change

  • Previous filing in this sequence was filed on 07 Feb 2023.
  • Current net transaction value: -$1,841,829.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REGN transaction

Common Stock

Options Exercise

Transaction value
$305,536
Shares
+800
Change %
+2.5%
Price
$381.92
Shares after
32,905
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Tax liability

Transaction value
$486,025
Shares
-589
Change %
-1.8%
Price
$825.17
Shares after
32,316
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Options Exercise

Transaction value
$1,136,940
Shares
+3,000
Change %
+9.3%
Price
$378.98
Shares after
35,316
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Tax liability

Transaction value
$1,818,675
Shares
-2,204
Change %
-6.2%
Price
$825.17
Shares after
33,112
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Sale

Transaction value
$31,959
Shares
-39
Change %
-0.12%
Price
$819.47
Shares after
33,073
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1, F2
REGN transaction

Common Stock

Sale

Transaction value
$41,023
Shares
-50
Change %
-0.15%
Price
$820.46
Shares after
33,023
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1, F3
REGN transaction

Common Stock

Sale

Transaction value
$39,427
Shares
-48
Change %
-0.15%
Price
$821.39
Shares after
32,975
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1, F4
REGN transaction

Common Stock

Sale

Transaction value
$14,806
Shares
-18
Change %
-0.05%
Price
$822.57
Shares after
32,957
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1, F5
REGN transaction

Common Stock

Sale

Transaction value
$3,297
Shares
-4
Change %
-0.01%
Price
$824.30
Shares after
32,953
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Sale

Transaction value
$10,733
Shares
-13
Change %
-0.04%
Price
$825.59
Shares after
32,940
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Sale

Transaction value
$3,317
Shares
-4
Change %
-0.01%
Price
$829.16
Shares after
32,936
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Sale

Transaction value
$5,810
Shares
-7
Change %
-0.02%
Price
$830.01
Shares after
32,929
Date
27 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Sale

Transaction value
$8,188
Shares
-10
Change %
-0.03%
Price
$818.81
Shares after
32,919
Date
28 Mar 2023
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Sale

Transaction value
$94,398
Shares
-115
Change %
-0.35%
Price
$820.85
Shares after
32,804
Date
28 Mar 2023
Ownership
Direct
Footnotes
F1, F6
REGN transaction

Common Stock

Sale

Transaction value
$116,639
Shares
-142
Change %
-0.43%
Price
$821.40
Shares after
32,662
Date
28 Mar 2023
Ownership
Direct
Footnotes
F1, F7
REGN transaction

Common Stock

Sale

Transaction value
$105,302
Shares
-128
Change %
-0.39%
Price
$822.67
Shares after
32,534
Date
28 Mar 2023
Ownership
Direct
Footnotes
F1, F8
REGN transaction

Common Stock

Sale

Transaction value
$149,072
Shares
-181
Change %
-0.56%
Price
$823.60
Shares after
32,353
Date
28 Mar 2023
Ownership
Direct
Footnotes
F1, F9
REGN transaction

Common Stock

Sale

Transaction value
$129,453
Shares
-157
Change %
-0.49%
Price
$824.54
Shares after
32,196
Date
28 Mar 2023
Ownership
Direct
Footnotes
F1, F10
REGN transaction

Common Stock

Sale

Transaction value
$200,565
Shares
-243
Change %
-0.75%
Price
$825.37
Shares after
31,953
Date
28 Mar 2023
Ownership
Direct
Footnotes
F1, F11
REGN transaction

Common Stock

Sale

Transaction value
$25,617
Shares
-31
Change %
-0.1%
Price
$826.36
Shares after
31,922
Date
28 Mar 2023
Ownership
Direct
Footnotes
F1
REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
250
Date
27 Mar 2023
Ownership
By 401(k) Plan

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

REGN transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-3,000
Change %
-13%
Price
$0.000000
Shares after
20,337
Date
27 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,000
Exercise price
$378.98
Footnotes
F1, F12
REGN transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-800
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
800
Exercise price
$381.92
Footnotes
F1, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 12 footnotes

Footnote F1

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 24, 2023.

Footnote F2

Represents volume-weighted average price of sales of 39 shares of Company stock on March 27, 2023 at prices ranging from $819.34 to $819.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.

Footnote F3

Represents volume-weighted average price of sales of 50 shares of Company stock on March 27, 2023 at prices ranging from $820.00 to $820.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.

Footnote F4

Represents volume-weighted average price of sales of 48 shares of Company stock on March 27, 2023 at prices ranging from $821.02 to $821.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.

Footnote F5

Represents volume-weighted average price of sales of 18 shares of Company stock on March 27, 2023 at prices ranging from $822.46 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.

Footnote F6

Represents volume-weighted average price of sales of 115 shares of Company stock on March 28, 2023 at prices ranging from $820.67 to $820.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.

Footnote F7

Represents volume-weighted average price of sales of 142 shares of Company stock on March 28, 2023 at prices ranging from $821.04 to $821.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.

Footnote F8

Represents volume-weighted average price of sales of 128 shares of Company stock on March 28, 2023 at prices ranging from $822.21 to $822.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.

Footnote F9

Represents volume-weighted average price of sales of 181 shares of Company stock on March 28, 2023 at prices ranging from $823.02 to $823.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.

Footnote F10

Represents volume-weighted average price of sales of 157 shares of Company stock on March 28, 2023 at prices ranging from $824.00 to $824.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.

Footnote F11

Represents volume-weighted average price of sales of 243 shares of Company stock on March 28, 2023 at prices ranging from $825.02 to $825.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.

Footnote F12

The stock option award vests in four equal annual installments, commencing one year after the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .